Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
6.42
-0.11 (-1.68%)
Oct 23, 2025, 11:21 AM EDT - Market open
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $9.8 million as of October 23, 2025. Its market cap has decreased by -71.95% in one year.
Market Cap
9.80M
Enterprise Value
3.90M
1-Year Change
-71.95%
Ranking
Category
Stock Price
$6.42
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $9.80M, a decrease of -82.88%. That is a compound annual growth rate of -33.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 10.70M | -22.19% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.80B |
| Johnson & Johnson | 462.11B |
| AbbVie | 408.76B |
| UnitedHealth Group | 330.91B |
| AstraZeneca | 259.08B |
| Novartis AG | 254.71B |
| Novo Nordisk | 245.28B |
| Abbott Laboratories | 221.98B |